Achillion Pharma

Home » Achillion Pharma

Secondary

Achillion Pharma

Achillion is a science-driven, patient-focused company seeking to leverage its strengths across the continuum from discovery to commercialization in its goal of providing better treatments for people with serious diseases.

Symbol

ACHN

Last Closing Price
$3.03

Shares
18,000,000

Effective Date
November 16, 2017

Underwriters
Goldman Sachs, Leerink Partners

To view the prospectus for Achillion Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253